As of the latest Form 4 filed Jul 10, 2026.
What Agios Pharm insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 68 most recent filings for AGIO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-08 | Backstrom Jay T. Director | AAward | +1.45K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Gheuens Sarah Chief Medical Officer | SSale | −4.01K | $37.56 | $151K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Gheuens Sarah, Chief Medical Officer | MExercise | +8.38K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Ballal Rahul D. Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | CAPELLO JEFFREY D Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Foster-Cheek Kaye I Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | FOUSE JACQUALYN A Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Ho Maykin Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Owen Adams Catherine Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Scadden David Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Smith Cynthia Director | MExercise | +2.82K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-13 | Owen Adams Catherine Director | MExercise | +1.98K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-16 | 2026-06-13 | CAPELLO JEFFREY D Director | MExercise | +1.98K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Burns James William Chief Legal Officer | SSale | −3.28K | $34.71 | $114K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Burns James William, Chief Legal Officer | MExercise | +8.50K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Gheuens Sarah Chief Medical Officer | SSale | −2.94K | $34.71 | $102K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Gheuens Sarah, Chief Medical Officer | MExercise | +8.50K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Jones Cecilia Chief Financial Officer | SSale | −3.14K | $34.71 | $109K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Jones Cecilia, Chief Financial Officer | MExercise | +8.50K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Milanova Tsveta Chief Commercial Officer | SSale | −3.26K | $34.71 | $113K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Milanova Tsveta, Chief Commercial Officer | MExercise | +8.50K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Viswanadhan Krishnan Chief Corp Dev & Strategy | SSale | −2.96K | $34.71 | $103K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Viswanadhan Krishnan, Chief Corp Dev & Strategy | MExercise | +8.10K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Goff Brian Chief Executive Officer | SSale | −6.60K | $34.71 | $229K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Goff Brian, Chief Executive Officer | MExercise | +13.5K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Goff Brian, Chief Executive Officer | SSale | −12.5K | $34.71 | $433K | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Goff Brian, Chief Executive Officer | MExercise | +25.5K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Viswanadhan Krishnan Chief Corp Dev & Strategy | SSale | −2.96K | $27.80 | $82.3K | Yes (planned) | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Viswanadhan Krishnan, Chief Corp Dev & Strategy | MExercise | +8.10K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Washburn Theodore James Jr. Principal Accounting Officer | SSale | −5.27K | $28.88 | $152K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Goff Brian Chief Executive Officer | SSale | −5.92K | $28.96 | $171K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Goff Brian, Chief Executive Officer | MExercise | +13.0K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Goff Brian, Chief Executive Officer | SSale | −8.27K | $28.96 | $239K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Goff Brian, Chief Executive Officer | MExercise | +18.0K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Goff Brian, Chief Executive Officer | SSale | −3.87K | $28.96 | $112K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Goff Brian, Chief Executive Officer | MExercise | +8.50K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William Chief Legal Officer | SSale | −1.16K | $28.96 | $33.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | MExercise | +3.92K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | SSale | −1.19K | $28.96 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | MExercise | +4.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | SSale | −1.68K | $28.96 | $48.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | MExercise | +5.67K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | SSale | −1.19K | $28.96 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burns James William, Chief Legal Officer | MExercise | +4.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Gheuens Sarah Chief Medical Officer | SSale | −1.19K | $28.96 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Gheuens Sarah, Chief Medical Officer | MExercise | +4.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Gheuens Sarah, Chief Medical Officer | SSale | −1.68K | $28.96 | $48.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Gheuens Sarah, Chief Medical Officer | MExercise | +5.67K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Gheuens Sarah, Chief Medical Officer | SSale | −1.19K | $28.96 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Gheuens Sarah, Chief Medical Officer | MExercise | +4.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia Chief Financial Officer | SSale | −1.57K | $28.96 | $45.6K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | MExercise | +5.30K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | SSale | −1.19K | $28.96 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | MExercise | +4.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | SSale | −1.68K | $28.96 | $48.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | MExercise | +5.67K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | SSale | −594.00 | $28.96 | $17.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Jones Cecilia, Chief Financial Officer | MExercise | +2.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Milanova Tsveta Chief Commercial Officer | SSale | −1.19K | $28.96 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Milanova Tsveta, Chief Commercial Officer | MExercise | +4.00K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Milanova Tsveta, Chief Commercial Officer | SSale | −1.68K | $28.96 | $48.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Milanova Tsveta, Chief Commercial Officer | MExercise | +5.67K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Washburn Theodore James Jr. Principal Accounting Officer | SSale | −798.00 | $28.96 | $23.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Washburn Theodore James Jr., Principal Accounting Officer | MExercise | +2.69K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Washburn Theodore James Jr., Principal Accounting Officer | SSale | −727.00 | $28.96 | $21.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Washburn Theodore James Jr., Principal Accounting Officer | MExercise | +2.45K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Washburn Theodore James Jr., Principal Accounting Officer | SSale | −698.00 | $28.96 | $20.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Washburn Theodore James Jr., Principal Accounting Officer | MExercise | +2.35K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AGIO’s full analysis or the market-wide insider trading feed. The tabs above jump to AGIO’s other SEC data.
Source: SEC Form 4 filings for AGIO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.